Position in IBRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,970,750
+$746,181 QoQ
Shares Held
225,100
+41.0% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#72
of 403 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names. IBRX ranks #45 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
402,605 | $31,511,893 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
90,543 | $30,312,890 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58,072 | $28,846,104 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
1,362,169 | $23,701,740 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
89,662 | $21,946,567 | |
| 6 | IMNM |
Immunome Inc.
|
859,076 | $18,203,820 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,880 | $14,266,595 | |
| 8 | CYTK |
Cytokinetics Inc
|
140,046 | $11,930,518 |
All Filings in IBRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,970,750 | 225,100 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,224,569 | 159,657 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $325,244 | 164,265 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $303,760 | 123,480 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $365,016 | 138,264 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $193,115 | 64,158 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $228,846 | 89,393 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $231,997 | 62,365 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $520,091 | 82,293 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $369,708 | 68,847 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $355,536 | 70,824 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $98,829 | 58,479 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $162,571 | 58,479 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $30,750 | 16,896 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $223,379 | 44,059 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $218,973 | 44,059 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $95,250 | 25,605 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $186,577 | 33,258 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $157,356 | 25,881 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $162,180 | 16,651 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $358,170 | 25,082 | Shares | Defined | 2024-05-17 | |
| 2021-03-31 | $335,944 | 14,151 | Shares | Defined | 2024-05-17 | |
| 2020-12-31 NK | — | 14,151 | Shares | Defined | 2024-05-24 | |
| 2020-09-30 NK | — | 14,151 | Shares | Defined | 2024-05-24 | |
| 2020-06-30 NK | — | 14,151 | Shares | Defined | 2024-05-24 | |
| No filing history on record for this holder in this stock. | ||||||